These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3965374)

  • 61. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].
    Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA
    Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
    Turbow MM; Ballon SC; Sikic BI; Koretz MM
    Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
    Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The level of steroid hormone receptors in endometrial cancer].
    Bieglmayer C; Spona J; Ulm R; Husslein P
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6211045
    [No Abstract]   [Full Text] [Related]  

  • 66. Estradiol and progesterone receptors in gynecologic sarcomas.
    Lantta M; Kärkkäinen J; Wahlström T; Widholm O
    Acta Obstet Gynecol Scand; 1984; 63(6):505-8. PubMed ID: 6507052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
    Kleine W; Fuchs A; deGregorio G; Geyer H
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leiomyomas: steroid receptor content. Variation within normal menstrual cycles.
    Soules MR; McCarty KS
    Am J Obstet Gynecol; 1982 May; 143(1):6-11. PubMed ID: 7081313
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of progestins and progesterone receptors in the treatment of breast cancer.
    Sedlacek SM; Horwitz KB
    Steroids; 1984 Dec; 44(6):467-84. PubMed ID: 6400150
    [No Abstract]   [Full Text] [Related]  

  • 71. Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy.
    Satoh Y; Ishikawa Y; Miyoshi T; Mukai H; Okumura S; Nakagawa K
    Virchows Arch; 2003 Feb; 442(2):173-8. PubMed ID: 12596070
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
    Soper JT; McCarty KS; Hinshaw W; Creasman WT; McCarty KS; Clarke-Pearson DL
    Am J Obstet Gynecol; 1984 Oct; 150(4):342-8. PubMed ID: 6486200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Uterine sarcoma: steroid receptors and response to hormonal therapy.
    Wade K; Quinn MA; Hammond I; Williams K; Cauchi M
    Gynecol Oncol; 1990 Dec; 39(3):364-7. PubMed ID: 2258084
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 76. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circannual rhythms in steroid receptor concentration in gynecologic and breast cancers.
    Chambers JT; Lawrence R; MacLusky N; Eisenfield A; Schwartz PE
    Am J Obstet Gynecol; 1987 Mar; 156(3):728-9. PubMed ID: 3826223
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Estrogen and progesterone receptors in the assessment of endometrial carcinoma].
    Gao YL
    Zhonghua Fu Chan Ke Za Zhi; 1984 Oct; 19(4):232-5, 258. PubMed ID: 6536440
    [No Abstract]   [Full Text] [Related]  

  • 80. [Metastatic lung tumor from uterine leiomyosarcoma].
    Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
    Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.